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Introduction
Antibody microarray technology has become a 
central tool for the identifi cation, quantitation and 
functional analysis of proteins. This high throughput 
proteomic technology enables effi cient and sensitive 
protein analysis thus accelerating protein profi ling 
studies for biomarker discovery (Kopf, E. and Zhar-
hary, D., 2007). 
Material and methods
PanoramaTM Antibody Arrays are kits that con-
tain nitrocellulose-coated glass slides spotted with 
84 to 725 antibodies. The series includes arrays 
specifi c for Cell Signaling proteins (Product code 
CSAA1), for MAPK & PKC Pathway proteins 
(Product code MPAA3), and for Gene Regulation 
proteins important in chromatin remodeling (Pro-
duct code GRAA2).  There is also an array for p53 
pathways proteins (Product code PPAA4), as well 
as a large array with 725 antibodies representing 
many biological pathways (Product code XP725). 
Protein extract samples from human, mouse, or rat 
cells and tissues can be assayed using these arrays. 
The extracts are labeled with Cy3 or Cy5 fl uores-
cent dyes and then applied to the array. After a 
short incubation and wash, the array is scanned and 
numerical values of the fl uorescence intensity are 
obtained. Numerical values for each spot are nor-
malized against that of antibodies to house-keeping 
gene proteins present on the array, to eliminate the 
effect of dye conjugation effi ciency.  Differences 
in protein expression between two samples can be 
assayed on one array by labeling samples with di-
fferent dyes (Cy3 or Cy5) and applying a mixture of 
both on the array.
Results
Many applications of the PanoramaTM Ab Micro-
array family of products have been reported. They 
were employed in identifying proteins involved in 
differentiation of F9 embryonic mouse stem cells by 
retinoic acid (Kopf, E., et al., 2005), and in the iden-
tifi cation of proteins involved in extracellular and in-
tracellular signaling components of the mammary ad-
ipose tissue and its interstitial fl uid in high-risk breast 
cancer patients  (Celis, J.E., et al., 2005). Other appli-
cations were the identifi cation of proteins involved in 
drug resistance (doxorubicin) in human breast cancer 
cells (Smith, L., et al., 2006), and the identifi cation of 
the cellular pathways involved in the maintenance of 
human embryonic stem cell pluripotency and viabil-
ity (Armstrong, L., et al., 2006). Antibody arrays are 
also useful in studying the effect of gene silencing by 
siRNA as demonstrated using LAP2β gene silencing 
as a model system. The antibody array was also used 
in protein/protein interaction studies to identify β-cat-
enin binding proteins in NIH-3T3 cells. All array re-
sults were confi rmed by using other immunochemical 
assays such as immunoblotting, immunoprecipitation 
or immunocytochemistry. 
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